Mini reviewPublished 2011
Does perivascular fat influence neural control of the saphenous vein? Implications in coronary artery bypass surgery (CABG).
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The saphenous vein (SV) is the most commonly used conduit for CABG but its patency rate is poor compared with the internal mammary artery (IMA). In conventional harvesting the saphenous vein’s outer layer, the adventitia, is damaged and this affects the perivascular nerves. In addition the cushion of perivascular fat (PVF) surrounding the vein is removed. The performance of SV grafts removed with surrounding cushion of fat intact, using a notouch technique, is markedly improved. This finding suggests that the outermost layers of the SV play a potentially important role in the success of this technique. In recent years there has been increasing interest in the potential ‘protective‘ role of the PVF surrounding blood vessels. In this mini-review we discuss evidence for the beneficial role of PVF in the improved performance of SV grafts prepared using a ‘no-touch’ technique and put forward the hypothesis that PVF may affect the neural control of grafts and perhaps vice versa. Perivascular fat. Perhaps the original suggestion for a beneficial role of perivascular fat (PVF) is based on a study in 1991 by Soltis and Cassis [1] who showed that perivascular adipose tissue altered the responsiveness of rat aortic rings in vitro. These authors compared the effects of various manipulations on aortic segments with PVF intact and PVF removed. There was a decreased sensitivity to the constrictor effect of norepinephrine in those aortic segments with PVF intact compared with those where PVF had been removed. In addition, electrical field stimulation caused a frequency-dependent contraction of intact aortic rings but had no response in ‘stripped’ segments. Interestingly, phentolamine blocked the contractile effects where PVF was intact, suggesting that PVF exerts its effect via the sympathetic neuroeffector system. More recently, Lohn et al [2] compared the constrictor effects of various compounds on rat aortic rings with and without PVF as well as demonstrating the existence of a transferable relaxing factor that was later named ‘adipocyte-derived relaxing factor’ (ADRF) [3]. Subsequently many studies have provided supporting evidence for the relaxant, or anti-contractile, effects of PVF. Current Neurobiology 2011 Volume 2 Issue 1: Apart from beneficial effects of PVF there is recent evidence that perivascular adipose tissue surrounding coronary arteries stimulates the release of pro-inflammatory cytokines and adipokines involved in the atherosclerotic process [4] with a recent review suggesting that crosstalk between PVF and blood vessels occurs involving three key aspects of vessel pathology: inflammation, vasoreactivity and smooth muscle cell proliferation [5]. Fat and the autonomic nervous system. The influence of the central nervous system (CNS) on fat has been discussed in a recent review in some detail [6]. In this context, white adipose tissue (WAT) is said to receive a noradrenergic innervation that is closely associated with blood vessels with noradrenaline implicated in the control of WAT blood flow. Neural tracing techniques have shown that CNS ‘control’ of WAT is from the paraventricular hypothalamus, noradrenergic tegmental system and caudal raphe nucleus, all part of sympathetic outflow [7, 8]. Over the last two decades WAT has been suggested as a source of factors involved in physiological function with adipose tissue being considered an endocrine organ. The synthesis and secretion of these adipocyte-derived factors is under control of the sympathetic nervous system with most studies factors being leptin and 71 Dashwood/ Loesch adiponection, both being negatively regulated by ßadrenoceptors. There is also some suggestion that the parasympathetic system is involved, via the nicotinic receptor [6]. CNS and leptin. Shortly after its discovery leptin was hailed as the key to understanding obesity via its hypothalamic satiety action although it is now recognised to influence many other physiologic processes including food intake, thermoregulation, fertility, sympathetic nerve activation, blood vessel tone and blood pressure (see the review by Richards et al [9]). In the CNS, central administration of leptin ‘modulates’ noradrenaline release in the paraventricular nucleus of female rats [10]. Leptin receptors are located in the hypothalamus, hippocampus and cerebral cortex where they regulate neural development. Leptin is also suggested to be a ‘neuroprotective’ agent since leptin administration protects in animal models of cerebral ischemic injury and hemiparkinsonism via pathways that are downstream of leptin receptor signalling all of which are pro-survival and antiapoptotic [11]. In terms of its ‘neural’ effects on blood vessels, Fruhbeck [12] showed that leptin administration increases sympathetic activity to kidney, adrenals and lumber regions but this not always accompanied by increased blood pressure. This author tested the hypothesis that leptin-induced nitric oxide (NO) release opposes the pressor effect of sympathoexcitation. Intravenous leptin caused a dose-dependent increase in serum NO concentration and when NO synthase (NOS) was inhibited by LNAME, leptin produced increased blood pressure (BP) and heart rate leading Fruhbeck to suggest there was a pivotal role of NO in the control of blood pressure after leptin administration [12]. This is supported by data generated by Mitchell et al [13] who studied the effect of intravenous leptin on arterial BP and blood flow in various vascular beds in conscious rats. Although intravenous leptin administration caused an increase in lumbar sympathetic activity there was no effect on BP or blood flow. However, administration of L-NAME increased arterial BP and caused vasoconstriction whereas leptin had no effect on arterial pressure or blood flow in the presence of sympathetic blockade. Taken together the authors conclude that the chronic haemodynamic actions of leptin are related to sympathetic activation. In vitro effects of lept
Subjects
CardiologySurgeryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectCardiology
- SubjectSurgery
- BylineArticles whose byline prints “Michael R Dashwood”
- BylineArticles whose byline prints “Andrzej Loesch”